News
April 2012 - HAI and the Alianza LAC-Global support the WHO’s Consultative Expert Working Group’s (CEWG) recommendation that negotiations begin on a binding biomedical R&D convention. There is an international consensus on the failures of the current R&D system and this recommendation brings to a close a more than 10 year effort by the international community to formulate a structural solution to a systemic failure in R&D meeting global health needs. Read the HAI/Alianza Policy Brief (EN): here and in Spanish (ES): here.
Publications
18 April 2012Press Release - Health activists and consumers ask for greater public return on EU health R&D spending and a turn to needs-driven innovation
29 November 2011
Executive Summary EU Policy Opportunities in Biomedical Innovation and the Public Good
29 June 2011
Joint-Open-Letter-Common-Strategic Framework (EN)
22 June 2011
An Essential Health and Biomedical R&D Treaty
20 May 2011
Consultation Response DG Research Green Paper
29 November 2010
Joint Statement Increasing Calls Within EU for New Models of Medical Innovation
Policy Briefs & Reports
May 2012 Joint HAI and Allianza LAC-Global Policy Brief - A binding biomedical R&D convention: a structural solution for systemic failure (EN) (ES)
April 2012 Joint HAI Europe - TACD Policy Paper: Time for the EU to lead on innovation: EU policy opportunities in biomedical innovation and the creation of public knowledge goods (EN)
October 2009 Joint HAI Europe - Oxfam Report Trading Away Access to Medicines (EN) (FR) (ES)
March 2009 Advanced Market Commitments: Current Realities & Alternate Approaches
